🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

R&D expert joins board of Genomics 🥼👋 Genomics #recruitment #careers #jobs #science #biotherapeutics #leadership #oxonnews #oxonhour #businessnews #businessintelligence thebusinessmagazine.co.uk/companies/rd-e…

✨ Looking back on 2024 ✨ Last year was as exciting one for us, from our biggest exit to date with the sale of Featurespace to Visa, to portfolio milestones from Hysata & Genomics. Here’s to continued progress in 2025!

Dr Jose-Carlos Gutiérrez-Ramos has joined the Board of Genomics! 👏 He is the Chief Science Officer at Danaher Corporation, has held senior drug discovery roles at Pfizer Inc., AbbVie, and GSK, and brings a wealth of experience across #biotechs and #pharma #science #tech

Genomics has been recognised in the Sunday Times 100 Tech, as one of Britain’s fastest growing private tech companies. The prestigious ranking was published this morning on The Times and The Sunday Times website.  👏🧬🚀🏆 thetimes.com/sunday-times-1…

It's the final day at #FOG2025 🧬🚀 This is your last opportunity to visit our Booth 49 & connect with the team. We look forward to what the day will bring and the onsite collaborations 👋

Our CEO and Founder Peter Donnelly was interviewed on BBC News (UK) yesterday evening regarding Rachel Reeves plans for investment in Oxford and Cambridge. As one of the UK's fastest growing private tech companies, we welcome the announcement. Watch here: bbc.co.uk/iplayer/episod…

Our President Dave Thornton and Head of Medical Seamus Harrison were at the House of Lords yesterday evening with Genomics England. #Genomics must be at the forefront of #prevention and the #future of NHS England. Thank you Baroness Nicola Blackwood for hosting!

Our Health Insights product has been featured in The Times and The Sunday Times. Bupa will be the first customer to offer our genetic test service in the UK. Our test is widely available in the US. thetimes.com/article/d92243…

We have been profiled in The Times and The Sunday Times this morning! Genetic testing is the natural step forward given the current healthcare landscape, as per the vision set out by Wes Streeting to move the NHS England from treatment to prevention. thetimes.com/business-money…

Our CEO and Founder Professor Sir Peter Donnelly was interviewed in The Telegraph about the genetics of obesity. 👏telegraph.co.uk/health-fitness…

Genomics has been featured in The i Paper! The article quotes our CEO Peter Donnelly saying genetic tests can also predict if people are likely to benefit from certain medicines, as well as whether they are likely to have side effects from them. 🏆🧬inews.co.uk/news/science/s…

We've been featured in Morning Brew ☕️! 👏The article, 'The Human Genome Project’s legacy is still yielding new advances', quotes our Founder Peter Donnelly looking back on the impact of this initiative, as well as what's on the horizon for the field: emergingtechbrew.com/stories/2025/0…

We are thrilled to partner with Nadeem Sarwar and Novo Nordisk 's Transformational Prevention Unit in joint efforts to tackle obesity, underpinned by our expertise in genetics. Read more: telegraph.co.uk/business/2025/…

🧬 The role of genomics in risk for common human diseases A talk by Seamus Harrison from Genomics at #GenomicMechanisms25 #science #Genome #Drug Novo Nordisk Foundation Center for Genomic Mechanisms Disease at Broad Institute